Download a PDF of CSL Behring's corporate brochure (English, 1.25MB)
Download a PDF of CSL Behring's corporate brochure (German, 1.25MB)
Explore an interactive version of our product pipeline.
Download a PDF of CSL Behring's global product portfolio (30KB)
|
CSL Behring Fact Sheet
Resources
-
Download this Fact Sheet (129kb)
At CSL Behring, we are passionate about improving the quality of life for people with rare diseases such as primary immune deficiencies, hemophilia, von Willebrand disease and genetic emphysema and to advancing critical care treatments and wound healing worldwide.
CSL Behring is a global leader in the plasma protein biotherapeutics industry. The company manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the treatment of immune deficiencies, coagulation disorders, such as hemophilia and von Willebrand disease, and inherited emphysema. Other products are used for the treatment of hereditary angioedema and burns, for the prevention of hemolytic diseases in the newborn and in cardiac surgery and organ transplantation.
The company also operates one of the world's largest plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit www.cslbehring.com.
|
|
|
|
Peter Turner |
Paul Perreault |
Val Romberg |
Gordon Naylor |
President |
Exec. VP,
Commercial Operations |
Sr. VP,
Global R&D |
Exec VP, Plasma, Planning and Logistics |
| Employees |
7,500 employees in 19 countries |
| Headquarters |
King of Prussia, Pennsylvania, USA |
| Manufacturing |
Bern, Switzerland: center of excellence for immunoglobulins
Marburg, Germany: center of excellence for coagulation products
Kankakee, Illinois, USA: center of excellence for Alpha1-proteinase inhibitor |
| R&D |
CSL integrated R&D includes facilities in Marburg, Germany; Bern, Switzerland; King of Prussia, Pennsylvania, USA; Tokyo, Japan; and Broadmeadows and Parkville, Australia |
| 2006/07 Sales |
Approximately U.S. $2.1 billion |
Return to Top
Plasma Collection Business
ZLB Plasma is one of the world’s largest plasma collection organizations. The company operates more than 70 collection centers in the United States and Germany. Headquarters are in Boca Raton, Florida. Testing laboratories are located in Knoxville, Tennessee and in Goettingen, Germany.
Return to Top
Therapeutic Focus
| Coagulation |
Therapies to treat bleeding disorders including hemophilia and von Willebrand disease |
| Immune Deficiencies |
Products used to treat immunological disorders, such as primary immune deficiency, Idiopathic Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome and hemolytic disease of the newborn |
| Pulmonary |
Therapies used to treat Alpha1-Antitrypsin Deficiency (genetic condition resulting in liver and lung failure) |
| Critical Care |
Critical care products for Hereditary Angioedema, treatment of shock and burns, and fluid replacement therapy |
| Wound Healing |
Therapies used in surgery and the treatment of wounds to facilitate healing |
Return to Top
|